Warner-Lambert to acquire $360 mil. Glaxo Wellcome OTC business for $1.05 bil..
This article was originally published in The Tan Sheet
Executive Summary
WARNER-LAMBERT's ACQUISITION OF $360 MIL. GLAXO WELLCOME OTC BUSINESS will give it the number-one position in the upper res-piratory products category in the U.S., Canada, Australia and the U.K., as well as the leading position in the first aid and lice treatments in the U.S., the company said. Warner-Lambert announced Dec. 19 that it has signed a letter of intent to acquire the Glaxo Wellcome OTC business for $1.05 bil.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning